Nitric Oxide

Nitric Oxide

SCHEMBL2546097

[N][O]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GUCY1A1GUCY1A2GUCY1B1GUCY1B2

The experimentally established mechanism targets of Nitric Oxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Oxide SCHEMBL3993955 0.67
Nitric Oxide SCHEMBL7560 0.67
Nitric Oxide SCHEMBL306589 0.58
Nitric Oxide SCHEMBL2731176 0.58
Nitric Oxide SCHEMBL2888647 0.58
SCHEMBL25271841 0.58
SCHEMBL16617245 0.58
Charcoal, Activated SCHEMBL1535100 0.58
Nitric Oxide SCHEMBL5104249 0.58
SCHEMBL23039391 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117883449-A ENPP1 inhibitors and their use for the treatment of cancer 里兰斯坦福初级大学理事会 2024-04-16 CN disclosed
CN-111372587-B ENPP1 inhibitors and their use for the treatment of cancer 里兰斯坦福初级大学理事会 2024-01-09 CN disclosed
CN-106795177-B BACE1 inhibitors 豪夫迈·罗氏有限公司 2019-04-23 CN disclosed
CN-106795177-A BACE1 inhibitors 豪夫迈·罗氏有限公司 2017-05-31 CN disclosed
CN-103282203-B Barrier laminate and production method thereof TOYO SEIKAN GROUP HOLDINGS, LTD. (JP) 2016-01-06 CN disclosed
CN-102596569-B Gas barrier laminate and method for producing same TOYO SEIKAN KAISHA LTD 2015-06-10 CN disclosed
EP-2816644-A1 Battery Novaled GmbH (DE) 2014-12-24 EP disclosed
US-20130265757-A1 LIGHT-EMITTING DEVICE PANASONIC CORPORATION (JP) 2013-10-10 US disclosed
CN-103282203-A Gas barrier laminate and method for producing same TOYO SEIKAN KAISHA LTD 2013-09-04 CN disclosed
CN-102596569-A Gas barrier laminate and method for producing same TOYO SEIKAN KAISHA LTD 2012-07-18 CN disclosed
EP-1054874-B1 SUBSTITUTED AMINOPHENYL ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS UPJOHN CO (US) 2002-08-28 EP disclosed
US-20020091116-A1 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades MILLENNIUM PHARMACEUTICALS, INC. 2002-07-11 US disclosed
EP-1216231-A2 INHIBITORS OF FACTOR Xa Millennium Pharmaceuticals, Inc. (US) 2002-06-26 EP disclosed
WO-2001019798-A2 INHIBITORS OF FACTOR Xa COR THERAPEUTICS INC. (US) 2001-03-22 WO disclosed
EP-1054874-A1 SUBSTITUTED AMINOPHENYL ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS PHARMACIA &amp; UPJOHN COMPANY (US) 2000-11-29 EP disclosed
US-6069141-A BACTERICIDES PHARMACIA & UPJOHN COMPANY (US) 2000-05-30 US disclosed
US-6022977-A Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids DUPONT PHARMACEUTICALS COMPANY (US) 2000-02-08 US disclosed
EP-0971906-A1 LIPASE CATALYZED DYNAMIC RESOLUTION OF ISOXAZOLINE THIOESTERS TO ISOXAZOLINE CARBOXYLIC ACIDS Du Pont Pharmaceuticals Company (US) 2000-01-19 EP disclosed
WO-1999041244-A1 SUBSTITUTED AMINOPHENYL ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS PHARMACIA & UPJOHN COMPANY (US) 1999-08-19 WO disclosed
WO-1998042687-A1 LIPASE CATALYZED DYNAMIC RESOLUTION OF ISOXAZOLINE THIOESTERS TO ISOXAZOLINE CARBOXYLIC ACIDS DU PONT PHARMACEUTICALS COMPANY (US) 1998-10-01 WO disclosed